Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-09 Purchase | 2026-02-11 5:15 pm | SpyGlass Pharma Inc. | SGP | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 3,690,000 | $16 | $59,040,000 | 2,054,678 (Indirect) | View |
| 2026-02-09 Purchase | 2026-02-11 4:30 pm | SpyGlass Pharma Inc. | SGP | Behbahani Ali Director 10% Owner | 937,500 | $16 | $15,000,000 | 1,357,263 (Indirect) | View |
| 2026-02-09 Purchase | 2026-02-11 4:30 pm | SpyGlass Pharma Inc. | SGP | Florence Anthony A. Jr. 10% Owner | 937,500 | $16 | $15,000,000 | 1,357,263 (Indirect) | View |
| 2026-02-09 Purchase | 2026-02-11 4:30 pm | SpyGlass Pharma Inc. | SGP | BASKETT FOREST 10% Owner | 937,500 | $16 | $15,000,000 | 1,357,263 (Indirect) | View |
| 2026-02-09 Purchase | 2026-02-11 4:30 pm | SpyGlass Pharma Inc. | SGP | New Enterprise Associates 17 L.P. NEA Partners 17 L.P. NEA 17 GP LLC 10% Owner | 937,500 | $16 | $15,000,000 | 6,035,038 (Direct) | View |
| 2026-02-09 Purchase | 2026-02-11 4:30 pm | SpyGlass Pharma Inc. | SGP | Yang Rick 10% Owner | 937,500 | $16 | $15,000,000 | 6,035,038 (Indirect) | View |
| 2026-02-09 Purchase | 2026-02-11 4:30 pm | SpyGlass Pharma Inc. | SGP | Makhzoumi Mohamad 10% Owner | 937,500 | $16 | $15,000,000 | 1,357,263 (Indirect) | View |
| 2026-02-09 Purchase | 2026-02-11 4:30 pm | SpyGlass Pharma Inc. | SGP | SANDELL SCOTT D 10% Owner | 937,500 | $16 | $15,000,000 | 1,357,263 (Indirect) | View |
| 2026-02-09 Purchase | 2026-02-11 4:30 pm | SpyGlass Pharma Inc. | SGP | Chang Carmen 10% Owner | 937,500 | $16 | $15,000,000 | 1,357,263 (Indirect) | View |
| 2026-02-09 Purchase | 2026-02-11 4:30 pm | SpyGlass Pharma Inc. | SGP | Mathers Edward T 10% Owner | 937,500 | $16 | $15,000,000 | 6,035,038 (Indirect) | View |
| 2026-02-09 Purchase | 2026-02-11 4:30 pm | SpyGlass Pharma Inc. | SGP | Walker Paul Edward 10% Owner | 937,500 | $16 | $15,000,000 | 1,357,263 (Indirect) | View |
| 2026-02-09 Purchase | 2026-02-11 4:09 pm | SpyGlass Pharma Inc. | SGP | Pardo Geoffrey B Director | 312,500 | $16 | $5,000,000 | 2,187,513 (Indirect) | View |
| 2026-02-09 Purchase | 2026-02-11 4:07 pm | SpyGlass Pharma Inc. | SGP | Khan Bilal Arshad Director | 135,000 | $16 | $2,160,000 | 276,877 (Indirect Direct) | View |
| 2026-02-09 Purchase | 2026-02-10 6:09 pm | SpyGlass Pharma Inc. | SGP | Nielsen Kirk G. Director | 165,000 | $16 | $2,640,000 | 3,310,619 (Indirect) | View |
| 2026-02-09 Purchase | 2026-02-10 6:08 pm | SpyGlass Pharma Inc. | SGP | Vensana Capital I GP LLC Vensana Capital I L.P. Nielsen Kirk G. Klein Peter Justin 10% Owner | 165,000 | $16 | $2,640,000 | 3,310,619 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-09 Conversion | 2026-02-11 5:15 pm | N/A N/A | SpyGlass Pharma Inc. | SGP | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 8,662,234 | $0 | 2,054,678 (Indirect) | View |
| 2026-02-09 Conversion(A) | 2026-02-11 5:13 pm | N/A N/A | SpyGlass Pharma Inc. | SGP | Nielsen Kirk G. Director | 3,145,619 | $0 | 3,310,619 (Indirect) | View |
| 2026-02-09 Conversion | 2026-02-11 4:30 pm | N/A N/A | SpyGlass Pharma Inc. | SGP | Behbahani Ali Director 10% Owner | 6,454,801 | $0 | 1,357,263 (Indirect) | View |
| 2026-02-09 Conversion | 2026-02-11 4:30 pm | N/A N/A | SpyGlass Pharma Inc. | SGP | Florence Anthony A. Jr. 10% Owner | 6,454,801 | $0 | 1,357,263 (Indirect) | View |
| 2026-02-09 Conversion | 2026-02-11 4:30 pm | N/A N/A | SpyGlass Pharma Inc. | SGP | BASKETT FOREST 10% Owner | 6,454,801 | $0 | 1,357,263 (Indirect) | View |
| 2026-02-09 Conversion | 2026-02-11 4:30 pm | N/A N/A | SpyGlass Pharma Inc. | SGP | New Enterprise Associates 17 L.P. NEA Partners 17 L.P. NEA 17 GP LLC 10% Owner | 5,097,538 | $0 | 6,035,038 (Direct) | View |
| 2026-02-09 Conversion | 2026-02-11 4:30 pm | N/A N/A | SpyGlass Pharma Inc. | SGP | Yang Rick 10% Owner | 5,097,538 | $0 | 6,035,038 (Indirect) | View |
| 2026-02-09 Conversion | 2026-02-11 4:30 pm | N/A N/A | SpyGlass Pharma Inc. | SGP | Makhzoumi Mohamad 10% Owner | 6,454,801 | $0 | 1,357,263 (Indirect) | View |
| 2026-02-09 Conversion | 2026-02-11 4:30 pm | N/A N/A | SpyGlass Pharma Inc. | SGP | SANDELL SCOTT D 10% Owner | 6,454,801 | $0 | 1,357,263 (Indirect) | View |
| 2026-02-09 Conversion | 2026-02-11 4:30 pm | N/A N/A | SpyGlass Pharma Inc. | SGP | Chang Carmen 10% Owner | 6,454,801 | $0 | 1,357,263 (Indirect) | View |
| 2026-02-09 Conversion | 2026-02-11 4:30 pm | N/A N/A | SpyGlass Pharma Inc. | SGP | Mathers Edward T 10% Owner | 5,097,538 | $0 | 6,035,038 (Indirect) | View |
| 2026-02-09 Conversion | 2026-02-11 4:30 pm | N/A N/A | SpyGlass Pharma Inc. | SGP | Walker Paul Edward 10% Owner | 6,454,801 | $0 | 1,357,263 (Indirect) | View |
| 2026-02-09 Conversion | 2026-02-11 4:09 pm | N/A N/A | SpyGlass Pharma Inc. | SGP | Pardo Geoffrey B Director | 1,875,013 | $0 | 2,187,513 (Indirect) | View |
| 2026-02-09 Conversion | 2026-02-10 6:09 pm | N/A N/A | SpyGlass Pharma Inc. | SGP | Nielsen Kirk G. Director | 20,631,077 | $0 | 3,310,619 (Indirect) | View |
| 2026-02-09 Conversion | 2026-02-10 6:08 pm | N/A N/A | SpyGlass Pharma Inc. | SGP | Vensana Capital I GP LLC Vensana Capital I L.P. Nielsen Kirk G. Klein Peter Justin 10% Owner | 20,631,077 | $0 | 3,310,619 (Indirect) | View |
| 2026-02-05 Option Award | 2026-02-09 5:05 pm | N/A 2036-02-05 | SpyGlass Pharma Inc. | SGP | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 27,400 | $0 | 27,400 (Indirect) | View |
| 2026-02-05 Option Award | 2026-02-09 4:58 pm | N/A 2036-02-05 | SpyGlass Pharma Inc. | SGP | Behbahani Ali Director 10% Owner | 27,400 | $0 | 27,400 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-09 4:54 pm | N/A 2036-02-05 | SpyGlass Pharma Inc. | SGP | Nielsen Kirk G. Director 10% Owner | 27,400 | $0 | 27,400 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-09 4:51 pm | N/A 2036-02-05 | SpyGlass Pharma Inc. | SGP | Scheiner Zachary Director | 27,400 | $0 | 27,400 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-09 4:50 pm | N/A 2036-02-05 | SpyGlass Pharma Inc. | SGP | Khan Bilal Arshad Director | 13,700 | $0 | 13,700 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-09 4:49 pm | N/A 2036-02-05 | SpyGlass Pharma Inc. | SGP | Dable Habib J Director | 27,400 | $0 | 27,400 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-09 4:48 pm | N/A 2036-02-05 | SpyGlass Pharma Inc. | SGP | Pardo Geoffrey B Director | 27,400 | $0 | 27,400 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-09 4:47 pm | N/A 2036-02-05 | SpyGlass Pharma Inc. | SGP | Dybbs Michael Director | 27,400 | $0 | 27,400 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-09 4:46 pm | N/A 2036-02-05 | SpyGlass Pharma Inc. | SGP | O'Farrell Elizabeth G. Director | 13,700 | $0 | 13,700 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-09 4:43 pm | N/A 2036-02-05 | SpyGlass Pharma Inc. | SGP | Dennewill James Robert Jr. Chief Operating Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-09 4:42 pm | N/A 2036-02-05 | SpyGlass Pharma Inc. | SGP | Pujara Chetan Pratap Chief R&D Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-09 4:41 pm | N/A 2036-02-05 | SpyGlass Pharma Inc. | SGP | Kahook Malik Y. See remarks | 105,000 | $0 | 105,000 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-09 4:40 pm | N/A 2036-02-05 | SpyGlass Pharma Inc. | SGP | Viret Jean-Frederic Chief Financial Officer | 17,500 | $0 | 17,500 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-09 4:39 pm | N/A 2036-02-05 | SpyGlass Pharma Inc. | SGP | Mooney Patrick H. Chief Executive Officer | 300,000 | $0 | 300,000 (Direct) | View |
Ownership | 2026-02-05 4:24 pm | N/A N/A | SpyGlass Pharma Inc. | SPG | Vensana Capital I GP LLC Vensana Capital I L.P. Nielsen Kirk G. Klein Peter Justin 10% Owner | 0 | $0 | 3,145,619 (Indirect) | View |
Ownership | 2026-02-05 4:05 pm | N/A N/A | SpyGlass Pharma Inc. | SGP | BASKETT FOREST 10% Owner | 0 | $0 | 6,454,801 (Indirect) | View |
Ownership | 2026-02-05 4:05 pm | N/A N/A | SpyGlass Pharma Inc. | SGP | Yang Rick 10% Owner | 0 | $0 | 5,097,538 (Indirect) | View |
Ownership | 2026-02-05 4:05 pm | N/A N/A | SpyGlass Pharma Inc. | SGP | Chang Carmen 10% Owner | 0 | $0 | 6,454,801 (Indirect) | View |
Ownership | 2026-02-05 4:05 pm | N/A N/A | SpyGlass Pharma Inc. | SGP | Florence Anthony A. Jr. 10% Owner | 0 | $0 | 6,454,801 (Indirect) | View |
Ownership | 2026-02-05 4:05 pm | N/A N/A | SpyGlass Pharma Inc. | SGP | Behbahani Ali Director 10% Owner | 0 | $0 | 6,454,801 (Indirect) | View |
Ownership | 2026-02-05 4:05 pm | N/A N/A | SpyGlass Pharma Inc. | SGP | Walker Paul Edward 10% Owner | 0 | $0 | 6,454,801 (Indirect) | View |
Ownership | 2026-02-05 4:05 pm | N/A N/A | SpyGlass Pharma Inc. | SGP | SANDELL SCOTT D 10% Owner | 0 | $0 | 6,454,801 (Indirect) | View |
Ownership | 2026-02-05 4:05 pm | N/A N/A | SpyGlass Pharma Inc. | SGP | New Enterprise Associates 17 L.P. NEA Partners 17 L.P. NEA 17 GP LLC 10% Owner | 0 | $0 | 5,097,538 (Direct) | View |
Ownership | 2026-02-05 4:05 pm | N/A N/A | SpyGlass Pharma Inc. | SGP | Mathers Edward T 10% Owner | 0 | $0 | 5,097,538 (Indirect) | View |